Sub-specialty Meetings

 


A unique one-day summit that brings together academics, industry, investors, commissioners, clinicians and patients to discuss strategies to accelerate the development of pharmaceutical and biological treatments for hearing loss and tinnitus.


Novartis, GSK, Eli Lilly and Company, Otonomy, Decibel Therapeutics, Autifony Therapeutics and Audion Therapeutics are some of the companies that will participate in this first-of-its-kind summit.



Registration
Registration will be open until 19 February 2018, but the event will be popular so secure your place soon.


For more information and to register, visit the website by clicking on
Translational Hearing Research Summit: Biological and Pharmacological Approaches

 


 

What
Translational Hearing Research Summit: Biological and Pharmacological Approaches

When
22 March 2018 to 22 March 2018

Where
London, UK

Contact Phone
+44 (0) 20 3227 6020

Contact Email
summit@hearingloss.org.uk